Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemia.

[1]  Y. Katsura.  Redefinition of lymphoid progenitors , 2002, Nature Reviews Immunology.

[2]  Z. Estrov,et al.  Outcome of Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia , 2000, Leukemia & lymphoma.

[3]  George Q. Daley,et al.  The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity , 1999, The Journal of experimental medicine.

[4]  C. Sawyers.  Chronic myeloid leukemia. , 1999, The New England journal of medicine.

[5]  S. Kamel‐Reid,et al.  Expression of p210 and p190 BCR‐ABL due to alternative splicing in chronic myelogenous leukaemia , 1998, British journal of haematology.

[6]  K. Kliche,et al.  Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemia , 1998, Leukemia.

[7]  L. Ailles,et al.  Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. , 1997, Blood.

[8]  A. Órfão,et al.  A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. , 1997, Blood.

[9]  A. Strife,et al.  New understanding of the pathogenesis of CML: a prototype of early neoplasia , 1997, Leukemia.

[10]  J. Reems,et al.  Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia , 1996, American journal of hematology.

[11]  J. Melo,et al.  p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. , 1996, Blood.

[12]  K. Akashi,et al.  Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. , 1996, Blood.

[13]  G. Martinelli,et al.  Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. , 1996, Blood.

[14]  V. Kaartinen,et al.  BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. , 1995, Blood.

[15]  E. Macintyre,et al.  Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. , 1995, Blood.

[16]  E. Linders,et al.  Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+). , 1995, Leukemia.

[17]  M. Greaves,et al.  Stem cell origins of leukaemia and curability. , 1993, British Journal of Cancer.

[18]  M. Greaves,et al.  Restricted oncogenicity of BCR/ABL p190 in transgenic mice. , 1992, Cancer research.

[19]  M. Greaves,et al.  Clonal characteristics of acute lymphoblastic cells derived from BCR/ABL p190 transgenic mice. , 1992, Oncogene.

[20]  I. Bernstein,et al.  Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. , 1992, Blood.

[21]  E. Estey,et al.  Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. , 1991, Blood.

[22]  R. Kurzrock,et al.  Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression. , 1991, Leukemia.

[23]  G. Grosveld,et al.  Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript. , 1990, Blood.

[24]  I. Jinnai.  In vitro growth response to G-CSF and GM-CSF by bone marrow cells of patients with acute myeloid leukemia. , 1990, Leukemia research.

[25]  T. Suda,et al.  Difference of cell lineage expression of haematopoietic progenitor cells in Philadelphia‐positive acute lymphoblastic leukaemia and chronic myelogenous leukaemia , 1988, British journal of haematology.

[26]  R. Kurzrock,et al.  Expression of c-abl in Philadelphia-positive acute myelogenous leukemia. , 1987, Blood.

[27]  N. Heisterkamp,et al.  Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia , 1987, Cell.

[28]  J. Adamson,et al.  Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. , 1987, The New England journal of medicine.

[29]  M. Greaves,et al.  A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia , 1987, Nature.

[30]  R. Kurzrock,et al.  A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia , 1987, Nature.

[31]  O. Witte,et al.  Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. , 1987, Science.

[32]  M. Beran,et al.  Response to Treatment in Acute Non‐lymphatic Leukaemia: Prognostic Value of Colony Forming and Colony Stimulating Capacities of Bone Marrow and Blood Cells Compared to Other Parameters , 1980, British journal of haematology.

[33]  M. Moore,et al.  Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics. , 1974, Blood.